wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28829729-51D523F4-9A60-4760-8426-BDA8B8F8D7C7
Q28829729-51D523F4-9A60-4760-8426-BDA8B8F8D7C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28829729-51D523F4-9A60-4760-8426-BDA8B8F8D7C7
Inferences of drug responses in cancer cells from cancer genomic features and compound chemical and therapeutic properties
P2860
Q28829729-51D523F4-9A60-4760-8426-BDA8B8F8D7C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28829729-51D523F4-9A60-4760-8426-BDA8B8F8D7C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9957d3c1c0acfcf4f3271d02b788d3df561fe100
P2860
Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer.